Friday, November 7, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Universal Health Services NYSE UHS Upgraded to Sector Perform with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Healthcare Services Stock Exchange
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On March 12, 2024, analyst Ben Hendrix of RBC Capital upgraded Universal Health Services (NYSE: UHS) to a Sector Perform rating and increased the price target to $183, up from $161. This adjustment reflects Hendrix’s continued optimism regarding the company’s potential for growth and success in the market.

Universal Health Services (UHS) Stock Shows Strong Performance on March 12, 2024

On March 12, 2024, Universal Health Services (UHS) saw a positive performance in the stock market. The healthcare company’s stock was trading near the top of its 52-week range and above its 200-day simple moving average, indicating strong price momentum. UHS shares opened at $170.67 on that day, which was $0.62 lower than its previous close. However, the stock quickly rebounded and saw an increase of $1.80 since the market last closed, representing a 1.05% rise in the price of UHS shares. This positive price momentum and increase in stock price reflect investor confidence in Universal Health Services. Investors may be optimistic about UHS’s future prospects, as the stock continues to perform well and show resilience in the market. Overall, the performance of UHS stock on March 12, 2024, demonstrates the company’s strong fundamentals and investor confidence in its future growth potential.

Universal Health Services (UHS) Stock Shows Promising Performance with Steady Revenue Growth and Increased EPS

On March 12, 2024, Universal Health Services (UHS) stock showed promising performance based on the financial data provided by CNN Money. The company reported a total revenue of $14.28 billion for the past year, showing a 6.59% increase compared to the previous year. In the fourth quarter, UHS generated $3.70 billion in revenue, marking a 3.95% increase from the previous quarter.

Net income for UHS was reported at $717.49 million for the year, indicating a 6.32% increase from the previous year. However, in the fourth quarter, the net income held flat at $216.31 million. Despite this, the company’s earnings per share (EPS) for the year stood at $10.23, showing an impressive 11.94% increase from the previous year. In the fourth quarter, the EPS remained flat at $3.16.

Overall, UHS demonstrated strong financial performance with steady revenue growth and an increase in net income and EPS over the past year. Investors may view these positive indicators as a sign of the company’s stability and potential for future growth. The flat net income and EPS in the fourth quarter could be attributed to various factors such as seasonal fluctuations or one-time expenses.

Tags: UHS
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Title Analysis of Options Trading Activity for Riot Platforms NASDAQ RIOT on March 12 2024

The Rise of Strategic Partnerships in Life Sciences: Trends Shaping the Future of Healthcare Innovation

ClearOne Inc Announces Special Dividend and Growth Strategy

Tech-banking-finance

Analyzing Apples Financial Performance and Market Standing

Recommended

Monte Rosa Therapeutics Stock

Monte Rosa Therapeutics Shares Surge on Major Novartis Partnership Expansion

2 months ago
Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Stock Analysis Criteo CRTO Receives Mixed Ratings and Price Targets

2 years ago
Cryptocurrency Stock Market Today

Navigating Uncertainties The Death Cross in Crypto Mining Stocks

2 years ago
Tesla Stock

Tesla’s AI Pivot: Strategic Masterstroke or High-Stakes Gamble?

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin ASML BioNTech Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Pharmaceutical Stock Defies Expectations with Surprising Rally

Xoma’s Acquisition Bid Reaches Critical Juncture

Kimberly-Clark Shares Plunge Following Major Acquisition

Baidu’s AI Ambitions Fuel Major Analyst Upgrade

IZEA Worldwide Faces Critical Test in Upcoming Earnings Report

French Government’s Surprising Defense of Temu Creates Political Storm

Trending

JPMorgan Equity Premium Income ETF Stock
Dividends

Uncovering the JEPI ETF’s Dual-Pronged Investment Approach

by Felix Baarz
November 7, 2025
0

The JPMorgan Equity Premium Income ETF employs a sophisticated two-component methodology that merges a carefully selected U.S....

SKYX Platforms Stock

SKYX Platforms Shares Tumble Ahead of Earnings Report

November 7, 2025
BigBear.ai Stock

BigBear.ai Shares Face Critical Test with Upcoming Earnings

November 7, 2025
Crinetics Stock

Pharmaceutical Stock Defies Expectations with Surprising Rally

November 7, 2025
Xoma Stock

Xoma’s Acquisition Bid Reaches Critical Juncture

November 7, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Uncovering the JEPI ETF’s Dual-Pronged Investment Approach
  • SKYX Platforms Shares Tumble Ahead of Earnings Report
  • BigBear.ai Shares Face Critical Test with Upcoming Earnings

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com